Neuroscience

NRG Therapeutics Announces Oversubscribed £50m ($67m) Series B Financing to Deliver Clinical Data in Parkinson’s and Proof of Concept in ALS/MND

Oversubscribed £50m Series B led by SV Health Investors’ Dementia Discovery Fund, alongside other new investors British Business Bank, M...

Dr. Robert Melillo and ‘A Moment of Xen’ join forces to bring ‘Brain-Based Wellness’ to National Radio, Digital Streaming TV, and social platforms

NEW YORK, Sept. 2, 2025 /PRNewswire/ -- 'A Moment of Xen', the acclaimed Tri-State talk show hosted by celebrated media...

Abridge Partnership Scales Ambient Clinical Intelligence Across Hartford HealthCare’s Clinical Enterprise

HARTFORD, Conn. & PITTSBURGH--(BUSINESS WIRE)--Abridge’s AI-powered ambient clinical intelligence platform has been selected by Hartford HealthCare, Connecticut’s most comprehensive healthcare...

Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss

Generic Saxenda® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in...

Pathway to Cures Portfolio Company Spark Biomedical Receives Wellcome Leap Award for Advancements in Women’s Health: Heavy Menstrual Bleeding

NEW YORK--(BUSINESS WIRE)--#NBDF--Pathway to Cures (P2C) congratulates Dr. Navid Khodaparast, PhD, co-founder and CSO of P2C portfolio company Spark Biomedical,...

Anavex Life Sciences Announces New Publication in Medical Journal: Blarcamesine Prevented Cognitive Impairment in Animal Model of Alzheimer’s Disease

Pre-Treatment with blarcamesine entirely prevented Abeta-induced cognitive decline Confirmed significant biomarker-response in hippocampus NEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE)...

error: Content is protected !!